Anafylaksi hos børn og voksne

Translated title of the contribution: Anaphylaxis in children and adults

Kirsten Skamstrup, Lene Heise Garvey, Carsten Bindslev-Jensen, Susanne Halken, Marianne Sjølin Frederiksen, Torsten Lauritsen, Thomas Houmann Petersen, Johannes Schmid, Sandra Viggers, Hans-Jørgen Malling

Research output: Contribution to journalJournal articleResearchpeer-review


In this review, we discuss anaphylaxis, which is a severe allergic condition with potentially life-threatening symptoms from airways or circulation and often associated with skin symptoms. First-line treatment is intramuscular adrenaline given by autoinjector for rapid administration. Initial dose for children < 25 kg is 0.15 mg and for children ≥ 25 kg and adults 0.3 mg. Repeated smaller doses of adrenaline is to be preferred. Patients with severe anaphylaxis will need an IV access for fluid replacement and supplementary oxygen. Antihistamines and steroids are only second-line treatment after adrenaline administration.
Translated title of the contributionAnaphylaxis in children and adults
Original languageDanish
Article numberV07200537
JournalUgeskrift for Laeger
Publication statusE-pub ahead of print - 9. Nov 2020

Fingerprint Dive into the research topics of 'Anaphylaxis in children and adults'. Together they form a unique fingerprint.

Cite this